Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly
Preventable adverse drug events (ADEs) represent a significant public health challenge for the older adult population, since they are associated with higher medical expenditures and more hospitalizations and emergency department (ED) visits. This study examines whether a novel medication risk predic...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-05-01
|
| Series: | Pharmacy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2226-4787/8/2/87 |
| _version_ | 1827716541072801792 |
|---|---|
| author | David L. Bankes Hubert Jin Stephanie Finnel Veronique Michaud Calvin H. Knowlton Jacques Turgeon Alan Stein |
| author_facet | David L. Bankes Hubert Jin Stephanie Finnel Veronique Michaud Calvin H. Knowlton Jacques Turgeon Alan Stein |
| author_sort | David L. Bankes |
| collection | DOAJ |
| description | Preventable adverse drug events (ADEs) represent a significant public health challenge for the older adult population, since they are associated with higher medical expenditures and more hospitalizations and emergency department (ED) visits. This study examines whether a novel medication risk prediction tool, the MedWise Risk Score™ (MRS), is associated with ADEs and other pertinent outcomes in participants of the Programs of All-Inclusive Care for the Elderly (PACE). Unlike other risk predictors, this tool produces actionable information that pharmacists can easily use to reduce ADE risk. This was a retrospective cross-sectional study that analyzed administrative medical claims data of 1965 PACE participants in 2018. To detect ADEs, we identified all claims that had ADE-related International Classification of Diseases and Health Related Problems, 10th revision (ICD-10) codes. Using logistic and linear regression models, we examined the association between the MRS and a variety of outcomes, including the number of PACE participants with an ADE, total medical expenditures, ED visits, hospitalizations, and hospital length of stay. We found significant associations for every outcome. Specifically, every point increase in the MRS corresponded to an 8.6% increase in the odds of having one or more ADEs per year (OR = 1.086, 95% CI: 1.060, 1.113), $1037 USD in additional annual medical spending (adjusted R<sup>2</sup> of 0.739; <i>p</i> < 0.001), 3.2 additional ED visits per 100 participants per year (adjusted R<sup>2</sup> of 0.568; <i>p</i> < 0.001), and 2.1 additional hospitalizations per 100 participants per year (adjusted R<sup>2</sup> of 0.804; <i>p</i> < 0.001). Therefore, the MRS can risk stratify PACE participants and predict a host of important and relevant outcomes pertaining to medication-related morbidity. |
| first_indexed | 2024-03-10T19:43:08Z |
| format | Article |
| id | doaj.art-b6fbbc641bae403ca82ba585246aac2e |
| institution | Directory Open Access Journal |
| issn | 2226-4787 |
| language | English |
| last_indexed | 2024-03-10T19:43:08Z |
| publishDate | 2020-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmacy |
| spelling | doaj.art-b6fbbc641bae403ca82ba585246aac2e2023-11-20T01:03:52ZengMDPI AGPharmacy2226-47872020-05-01828710.3390/pharmacy8020087Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the ElderlyDavid L. Bankes0Hubert Jin1Stephanie Finnel2Veronique Michaud3Calvin H. Knowlton4Jacques Turgeon5Alan Stein6Applied Precision Pharmacotherapy Institute, Tabula Rasa HealthCare, Moorestown, NJ 08057, USAHealthcare Analytics, Tabula Rasa HealthCare, Moorestown, NJ 08057, USAHealthcare Analytics, Tabula Rasa HealthCare, Moorestown, NJ 08057, USAPrecision Pharmacotherapy Research and Development Institute, Tabula Rasa HealthCare, Lake Nona, Orlando, FL 32827, USAChief Executive Officer, Tabula Rasa HealthCare, Moorestown, NJ 08057, USAPrecision Pharmacotherapy Research and Development Institute, Tabula Rasa HealthCare, Lake Nona, Orlando, FL 32827, USAHealthcare Analytics, Tabula Rasa HealthCare, Moorestown, NJ 08057, USAPreventable adverse drug events (ADEs) represent a significant public health challenge for the older adult population, since they are associated with higher medical expenditures and more hospitalizations and emergency department (ED) visits. This study examines whether a novel medication risk prediction tool, the MedWise Risk Score™ (MRS), is associated with ADEs and other pertinent outcomes in participants of the Programs of All-Inclusive Care for the Elderly (PACE). Unlike other risk predictors, this tool produces actionable information that pharmacists can easily use to reduce ADE risk. This was a retrospective cross-sectional study that analyzed administrative medical claims data of 1965 PACE participants in 2018. To detect ADEs, we identified all claims that had ADE-related International Classification of Diseases and Health Related Problems, 10th revision (ICD-10) codes. Using logistic and linear regression models, we examined the association between the MRS and a variety of outcomes, including the number of PACE participants with an ADE, total medical expenditures, ED visits, hospitalizations, and hospital length of stay. We found significant associations for every outcome. Specifically, every point increase in the MRS corresponded to an 8.6% increase in the odds of having one or more ADEs per year (OR = 1.086, 95% CI: 1.060, 1.113), $1037 USD in additional annual medical spending (adjusted R<sup>2</sup> of 0.739; <i>p</i> < 0.001), 3.2 additional ED visits per 100 participants per year (adjusted R<sup>2</sup> of 0.568; <i>p</i> < 0.001), and 2.1 additional hospitalizations per 100 participants per year (adjusted R<sup>2</sup> of 0.804; <i>p</i> < 0.001). Therefore, the MRS can risk stratify PACE participants and predict a host of important and relevant outcomes pertaining to medication-related morbidity.https://www.mdpi.com/2226-4787/8/2/87Programs of All-Inclusive Care for the ElderlyPACEmedical expendituresmedication risk stratificationmedicareadverse drug events |
| spellingShingle | David L. Bankes Hubert Jin Stephanie Finnel Veronique Michaud Calvin H. Knowlton Jacques Turgeon Alan Stein Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly Pharmacy Programs of All-Inclusive Care for the Elderly PACE medical expenditures medication risk stratification medicare adverse drug events |
| title | Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly |
| title_full | Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly |
| title_fullStr | Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly |
| title_full_unstemmed | Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly |
| title_short | Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly |
| title_sort | association of a novel medication risk score with adverse drug events and other pertinent outcomes among participants of the programs of all inclusive care for the elderly |
| topic | Programs of All-Inclusive Care for the Elderly PACE medical expenditures medication risk stratification medicare adverse drug events |
| url | https://www.mdpi.com/2226-4787/8/2/87 |
| work_keys_str_mv | AT davidlbankes associationofanovelmedicationriskscorewithadversedrugeventsandotherpertinentoutcomesamongparticipantsoftheprogramsofallinclusivecarefortheelderly AT hubertjin associationofanovelmedicationriskscorewithadversedrugeventsandotherpertinentoutcomesamongparticipantsoftheprogramsofallinclusivecarefortheelderly AT stephaniefinnel associationofanovelmedicationriskscorewithadversedrugeventsandotherpertinentoutcomesamongparticipantsoftheprogramsofallinclusivecarefortheelderly AT veroniquemichaud associationofanovelmedicationriskscorewithadversedrugeventsandotherpertinentoutcomesamongparticipantsoftheprogramsofallinclusivecarefortheelderly AT calvinhknowlton associationofanovelmedicationriskscorewithadversedrugeventsandotherpertinentoutcomesamongparticipantsoftheprogramsofallinclusivecarefortheelderly AT jacquesturgeon associationofanovelmedicationriskscorewithadversedrugeventsandotherpertinentoutcomesamongparticipantsoftheprogramsofallinclusivecarefortheelderly AT alanstein associationofanovelmedicationriskscorewithadversedrugeventsandotherpertinentoutcomesamongparticipantsoftheprogramsofallinclusivecarefortheelderly |